The man who created a drug President Trump is taking to help recover from COVID-19 once mentored a virologist known as the Wuhan “Bat Woman.”
Dr. Ralph Baric, who led the team that developed the pharmaceutical remdesivir, also worked on gain-of-function research in The United States before the project was defunded by the US government.
In 2014, the White House Office of Science and Technology Policy asked researchers working on ‘gain-of-function’ experiments on influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) to stop their work until a risk assessment was completed.
NPR wrote, “The Obama administration was concerned about any research that could make the viruses more dangerous, so they wanted to stop and review studies to see if they could make these germs capable of causing more disease or spreading easily through the air.”
Baric and his team at UNC Chapel Hill received the following letter in 2014, explaining because their grant is currently funded, “this pause is voluntary.”
After receiving the notification, Baric said, “The NIH has asked me to stop those experiments and so we have stopped those experiments.”
“I don’t think it’s wise or appropriate for us to create large risks that don’t already exist,” says David Relman, a microbiologist at Stanford University and critic of risky gain-of-function research.
In a 2014 NPR article about the “risky” labs, the left-leaning outlet asked, “What if this lab-made superflu escaped?”
A Chinese doctor named Shi Zhengli, known as the “Bat Woman,” was a lead researcher alongside Baric at the UNC Chapel Hill lab.
In 2015, shortly after their research was defunded, Zhengli and Baric published an article for Nature Medicine titled, “A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.”
In the article, the virologists explain “the emergence potential (that is, the potential to infect humans) of circulating bat CoVs, we built a chimeric virus encoding a novel, zoonotic CoV spike protein—from the RsSHC014-CoV sequence that was isolated from Chinese horseshoe bats.”
After the UN Chapel Hill research was shut down, Dr. Shi Zhengli became a lead researcher at the Wuhan Institute of Virology of the Chinese Academy of Sciences, and Director of the Center for Emerging Infectious Diseases.
The Wuhan Institute of Virology has been the focus of many prominent scientists and political figures who claim the lab was likely the source of a leaked manmade virus.
For example, a 26-page paper led by Chinese virologist Li-Meng Yan claims SARS-CoV-2 and its closest ancestor RaTG13 were both engineered in a lab.
Dr. Yan previously worked in the WHO reference lab, the top coronavirus lab in the world, before fleeing to America in order to try and get the word out about what she says is a manmade virus “intentionally” released by the Chinese government.
While investigating the origin of the COVID-19 virus during the initial outbreak in Wuhan, Dr. Yan found evidence pointing towards an intentional release from Zhengli’s Wuhan Institute of Virology and a cover-up by China and the WHO.
After Dr. Zhengli left for Wuhan, Dr. Baric started working on coronavirus treatments.
According to a North Carolina newspaper, “One of his [Baric] favorite books was ‘The Biological Time Bomb,’ which predicted things like monoclonal antibodies and recombinant DNA in the 1960s. Those ideas of treating infections with antibodies cloned out of a human who had a viral infection, then combining genetic material from different sources to create DNA molecules in a lab, stuck with him.”
Essentially, Baric has been obsessed with altering human DNA for decades.
One treatment Baric is involved with, known as remdesivir, was created six years ago.
When COVID-19 began spreading, Baric, who is one of the lead coronavirus experts in the world and mentored the woman accused of allowing the virus to escape the Wuhan lab, conveniently had a possible treatment.
Also convenient is the $6.5 billion Fauci’s NIH has given Gilead to research the drug over the years.
A spokesperson said Gilead received around $1 billion in NIH funding in 2020 alone.
The Center for Integration of Science Director Fred Ledley said, “Although it appears that remdesivir was approved in record time, this drug would not be available today if the NIH and others had not invested billions of dollars over the past decades in basic research on how different viruses work and the chemistry of nucleosides.”
An analyst calculated the drug could yield $2.3 billion in revenue for Gilead this year.
After President Trump announced he received a positive COVID-19 test on Friday, he was sent to Walter Reed Hospital that evening.
The president’s treatment at the military military center includes a synthetic antibody treatment called Regeneron combined with remdesivir.
These drugs have serious side-effects and are meant for individuals suffering extremely from COVID-19, unlike POTUS, who had mild symptoms.
Alex Jones exposed the dangerous situation President Trump is in during a special report published on Saturday.
On Saturday, Jon Rappoport explained how the combination of these experimental drugs could be extremely dangerous to President Trump.
Is Dr. Baric taking advantage of his knowledge of coronavirus to make a fortune off selling treatments or is he trying to help save people from a virus he likely knows was created by man?